Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juliette Soret

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
La Revue Du Praticien|June 23, 2021
[Myeloproliferative syndromes]Juliette Soret, Kiladjian Kiladjian
Bulletin Du Cancer|August 7, 2016
[Not Available]Juliette Soret, Jean-Jacques Kiladjian
La Revue Du Praticien|December 30, 2025
[Venous diseases of the liver: what are we talking about?]Audrey Payancé, Juliette Soret-Dulphy
Journal of Hepatology|September 29, 2020
Benefits of molecular profiling with next-generation sequencing for the diagnosis and prognosis of myeloproliferative neoplasms in splanchnic vein thrombosisJean-Jacques Kiladjian, Pierre-Edouard Debureaux, Aurélie Plessier, et al.
Haematologica|August 16, 2019
Masked polycythemia vera: analysis of a single center cohort of 2480 red cell massesNabih Maslah, Juliette Soret, Christine Dosquet, et al.
Blood|September 4, 2014
Impact of acute and chronic graft-versus-host disease on human B-cell generation and replicationSalomé Glauzy, Juliette Soret, Isabelle Fournier, et al.
Blood Cancer Journal|October 6, 2018
Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivoEmmanuelle Verger, Juliette Soret-Dulphy, Nabih Maslah, et al.
Therapie|February 28, 2021
[An example of Clinical Investigations Center reorganization during the COVID-19 pandemic French national lockdown]Zineb Ghrieb, Souhil Allaoua, Jin Huang, et al.
Haematologica|June 27, 2020
Anemia and hemodilution: analysis of a single center cohort based on 2,858 red cell mass measurementsLouis Drevon, Nabih Maslah, Juliette Soret-Dulphy, et al.
Clinics and Research in Hepatology and Gastroenterology|July 12, 2020
Risk factors for vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liverJuliette Soret, Dominique Debray, Flore Sicre de Fontbrune, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
La Revue Du Praticien|June 23, 2021
[Myeloproliferative syndromes]Juliette Soret, Kiladjian Kiladjian
Bulletin Du Cancer|August 7, 2016
[Not Available]Juliette Soret, Jean-Jacques Kiladjian
La Revue Du Praticien|December 30, 2025
[Venous diseases of the liver: what are we talking about?]Audrey Payancé, Juliette Soret-Dulphy
Journal of Hepatology|September 29, 2020
Benefits of molecular profiling with next-generation sequencing for the diagnosis and prognosis of myeloproliferative neoplasms in splanchnic vein thrombosisJean-Jacques Kiladjian, Pierre-Edouard Debureaux, Aurélie Plessier, et al.
Haematologica|August 16, 2019
Masked polycythemia vera: analysis of a single center cohort of 2480 red cell massesNabih Maslah, Juliette Soret, Christine Dosquet, et al.
Blood|September 4, 2014
Impact of acute and chronic graft-versus-host disease on human B-cell generation and replicationSalomé Glauzy, Juliette Soret, Isabelle Fournier, et al.
Blood Cancer Journal|October 6, 2018
Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivoEmmanuelle Verger, Juliette Soret-Dulphy, Nabih Maslah, et al.
Therapie|February 28, 2021
[An example of Clinical Investigations Center reorganization during the COVID-19 pandemic French national lockdown]Zineb Ghrieb, Souhil Allaoua, Jin Huang, et al.
Haematologica|June 27, 2020
Anemia and hemodilution: analysis of a single center cohort based on 2,858 red cell mass measurementsLouis Drevon, Nabih Maslah, Juliette Soret-Dulphy, et al.
Clinics and Research in Hepatology and Gastroenterology|July 12, 2020
Risk factors for vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liverJuliette Soret, Dominique Debray, Flore Sicre de Fontbrune, et al.
Pageof 3